tenofovir disoproxil
PolandDrugs containing this active substance
-
This medicine is used in adult patients (18 years and older) with human immunodeficiency virus type 1 (HIV-1) infection, where previous antiretroviral therapy has not failed and the infection has been controlled for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicinal product is used in adults and adolescents (from 12 to 18 years of age weighing at least 35 kg) for the treatment of HIV-1 infection. It may also be used to reduce the risk of HIV infection in adults and adolescents aged 12 to 18 years (weighing at least 35 kg), provided it is taken daily in conjunction with safe sex practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR03
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.
-
The medicinal product is used in adults and adolescents (from 12 to 18 years of age weighing at least 35 kg) for the treatment of HIV-1 infection. It may also be used to reduce the risk of HIV-1 infection in adults and adolescents meeting the above criteria, provided it is taken daily in conjunction with safe sex practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR03
Manufacturer: Tillomed Malta Limited
-
The medicine is used in the treatment of HIV infection (in adults and adolescents aged 12–18 years weighing at least 35 kg) and in the treatment of chronic hepatitis B (in adults and adolescents aged 12–18 years).
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: Pharmadox Healthcare Ltd.
-
The medicinal product is used in the treatment of HIV infection and chronic hepatitis B (HBV). It may be used in adults and adolescents (from 12 to less than 18 years of age) of appropriate body weight.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: Laboratori FUNDACIO DAU Pharmadox Healthcare Ltd.
-
The medicine is used to treat HIV infection and to treat chronic hepatitis B (HBV). In the case of HIV, it must always be taken in combination with other medicines.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: APL Swift Services (Malta) Ltd., Arrow Generiques - Lyon, Generis Farmacêutica, S.A.
-
The medicinal product is used to treat HIV infection and chronic hepatitis B (HBV). In the case of HIV, it must always be used in combination with other medicines.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: Aurobindo Pharma B.V.
-
The medicinal product is used in the treatment of HIV infection (in adults and adolescents aged 12–18 years who have been previously treated with other medicines) and in the treatment of chronic hepatitis B (in adults and adolescents aged 12–18 years).
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicinal product is used in the treatment of HIV infection and in the treatment of chronic hepatitis B (HBV infection). In people with HIV, it must always be used in combination with other medicines.
Form: tablets, film-coated
Active substance Dosage tenofovir disoproxil 245 mg ATC: J05AF07
Manufacturer: S.C. Zentiva S.A.